MedTrace Logo

PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing Gum

NCT01319578 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2011-11-15

No results posted yet for this study

Summary

The specific purpose of this study is to describe the characteristics of the K2CG chewing gum, specifically as it relates to duration of gum chewing (exposure), timing of gum chewing in relation to a meal, and dose of K2CG chewing gum.

Conditions

Interventions

OTHER

K2CG chewing gum

Fasting: Chew gum 15 minutes Post meal: Begin chewing 45 minutes post meal

OTHER

K2CG chewing gum

Fasting: Chew gum 30 minutes Post meal: Begin chewing 30 minutes post meal

OTHER

K2CG chewing gum

Fasting: Chew gum for 45 minutes Post meal: Begin chewing gum 15 minutes post meal

OTHER

K2CG chewing gum

Fasting: Chew gum for 60 minutes Post meal: Being chewing gum 5 minutes post meal

Sponsors & Collaborators

  • CM&D Pharma Limited

    collaborator INDUSTRY

  • Denver Nephrologists, P.C.

    lead OTHER

Principal Investigators

  • Geoffrey A Block, MD · Denver Nephrologists, PC

Study Design

Allocation
NON_RANDOMIZED
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01319578 on ClinicalTrials.gov